4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-042812
EVP & Chief Commercial Officer sold 1,009 shares at an average $94.82 ($95,670)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-19 | Sale : show line 1 in the form | −437 | $94.63 | $41,353 | 26,280 | D |
| 2021-06-21 | Sale : show line 2 in the form | −572 | $94.96 | $54,317 | 25,708 | D |
| Open-market sales · 1,009 sh · avg $94.82 · $95,670 | ||||||
Loading xslF345X03/doc4.xml…